Key points
- ADHD medicines for adults fall into two families: stimulants (amphetamine and methylphenidate products, Schedule II) and nonstimulants such as atomoxetine and viloxazine, which are not controlled substances.
- The UK NICE guideline recommends lisdexamfetamine or methylphenidate as first-line medication for adults, and atomoxetine for adults who cannot tolerate them or whose symptoms have not responded to separate 6-week trials of each.
- Since a May 2023 FDA class update, every prescription stimulant label carries a boxed warning on abuse, misuse and addiction and tells prescribers to assess that risk before and throughout treatment.
- Not every ADHD medicine is labeled for adults: Concerta is labeled for ages 6 to 65, while guanfacine extended-release (Intuniv) and the Daytrana patch are labeled only for children and teens.
- Centanafadine (Simtriyo) was approved on July 24, 2026, but under its approval letter it may be marketed only after the DEA publishes a scheduling rule, which had not happened as of October 19, 2026.
- On October 19, 2026, the FDA listed mixed amphetamine salts tablets, lisdexamfetamine and extended-release methylphenidate tablets as current shortages.
- No US adult ADHD treatment guideline from APSARD had been published as of October 19, 2026.
How to use this guide
This guide explains the medications used for ADHD in adults: what each one is, how it works, what its FDA label says about adults, its common side effects and warnings, and how the choices compare. Each medication page is built on the current FDA label, with guidelines and peer-reviewed research for the questions labels do not answer.
Two things this guide does not do. It does not give doses, because the right dose depends on your history, your health and how you respond, and is set and adjusted by a prescriber. And it never tells you to start, stop or change a medication. Use it to understand your options and to bring better questions to your appointment.
- Understand. How the medications work, how stimulants and nonstimulants differ, how a first medication is chosen, and safety topics that apply to all of them.
- Compare. A page for each medication and side-by-side comparisons of common choices.
- Before you start or stop. Practical pages on planning changes with your prescriber.
If you are still wondering whether ADHD is the explanation, start with the Adult ADHD Symptoms Guide. Prescribing rules in each state are covered in the New York and New Jersey guides.
ADHD medications at a glance
| Group | Examples (generic, brand) | Controlled? | Adults on the FDA label? |
|---|---|---|---|
| Amphetamine stimulants | Mixed amphetamine salts (Adderall, Adderall XR, Mydayis), lisdexamfetamine (Vyvanse), dextroamphetamine | Schedule II | Adderall XR and Vyvanse: yes. Brand Adderall tablets are listed as discontinued in the October 2026 Orange Book; generic tablets remain. Mydayis: 13 and older. Dexedrine: ADHD label covers ages 6 to 16. The Xelstrym patch: yes. |
| Methylphenidate stimulants | Methylphenidate (Ritalin, Concerta), dexmethylphenidate (Focalin, Focalin XR), Azstarys | Schedule II (Azstarys also contains a Schedule IV prodrug) | Ritalin tablets: yes. Concerta: ages 6 to 65. Focalin XR: adult trial on the label. Azstarys: 6 and older. |
| Norepinephrine reuptake inhibitors | Atomoxetine (Strattera), viloxazine (Qelbree) | No | Yes, both. Each carries a boxed warning on suicidal thoughts and behaviors: Strattera's addresses pediatric patients, Qelbree's all patients. Brand Strattera is listed as discontinued in the October 2026 Orange Book; generic atomoxetine remains. |
| Alpha-2 agonists | Guanfacine extended-release (Intuniv), clonidine extended-release | No | No. Labeled for children and teens; adult use is off-label. |
| Newly approved | Centanafadine (Simtriyo) | Schedule to be determined | Approved for adults and children 6 and older, but not marketed until DEA scheduling. |
| Off-label options | Bupropion (Wellbutrin) and others | Bupropion: no | Not approved for ADHD. |
Within each stimulant family, products differ mainly in how the medicine is released: immediate-release tablets, beads that release in stages, an osmotic pump tablet, prodrugs the body converts to the active drug, and skin patches. Extended-release medications explained covers how each design works, and generics and authorized generics explains what "equivalent" means on a pharmacy label.
How a medication is chosen
There is no single correct first medication for adult ADHD. The labels say amphetamine and methylphenidate products block the reuptake of norepinephrine and dopamine and increase their release, though the exact way they relieve ADHD symptoms is not known. In a 2018 network meta-analysis in Lancet Psychiatry, amphetamines had a larger short-term effect in adults than methylphenidate or atomoxetine, and both stimulant classes were less well tolerated than placebo. A 2025 analysis of 113 adult trials found that the medications were not efficacious on quality of life, and that longer-term evidence is underinvestigated.
Guidelines describe the checks that come before a first prescription. NICE says the assessment should cover other mental health conditions, the risk of substance misuse and diversion, medical history and current medications, weight, pulse, blood pressure and a cardiovascular assessment. It says an ECG is not needed unless there are specific heart-related features or risks. A 2024 American Family Physician review says nonstimulants are indicated when stimulants are contraindicated, not tolerated or ineffective. Beyond that, the choice turns on practical things: which hours of the day matter most, whether a capsule can be opened, what a plan covers, and what is in stock.
Safety: what every label says
Some warnings apply across a whole family of medicines. All stimulants carry the boxed warning on abuse, misuse and addiction. They must not be taken with an MAOI antidepressant or within 14 days of stopping one, because of the risk of a hypertensive crisis. Their labels report average rises of about 2 to 4 mm Hg in blood pressure and 3 to 6 beats per minute in heart rate, and call for monitoring. Medication Guides tell patients to call the prescriber or go to the nearest emergency room right away for chest pain, shortness of breath or fainting.
The evidence on addiction is more reassuring than many people expect when the medicine is taken as prescribed. In a study of nearly 3 million US adolescents and adults with ADHD, months on ADHD medication carried 35% (men) and 31% (women) lower odds of substance-related emergency visits than months off it. Misuse is still real: in 2021 to 2022 national survey data, 25.3% of adults who used prescription stimulants reported misusing them.
- Side effects in adults, including sleep, appetite and weight and anxiety
- Drug interactions and alcohol
- Misuse and addiction risk
- When it seems to stop working
- Stopping a medication safely
- Questions to ask before starting a medication
Heart and blood pressure questions are covered in more depth in ADHD medication heart and blood pressure safety.
Prescriptions, shortages and getting care
Because most stimulants are Schedule II, federal law prohibits refills: each supply needs a new prescription. New York allows up to a 30-day supply, or up to three months when the prescriber marks the prescription for attention deficit disorder. New Jersey limits each prescription to 30 days, with multiple dated prescriptions allowed up to 90 days, and since July 8, 2026 requires in-person visits for adults located in New Jersey who start a stimulant by telehealth. The federal permission to prescribe controlled medicines by telemedicine without a prior in-person visit runs through December 31, 2026. Nonstimulants such as atomoxetine and viloxazine are not controlled, so these Schedule II rules do not apply to them.
- New York's stimulant prescription rules and shortages in New York
- New Jersey's stimulant prescription rules and the 2026 telehealth law
- What ADHD medication costs, and how to pay less
Dr. John C. Shershow, M.D. is a psychiatrist who focuses on adult ADHD. He evaluates adults 18 and older, plans treatment, manages medication when it is appropriate and follows up by secure video, for patients located in New York or New Jersey at the time of the visit. No prescription is promised in advance: whether medication fits, and which one, comes out of the evaluation. See medication management in New York City, medication management in New Jersey and adult ADHD treatment.
Understand
How ADHD medications work
Stimulants and nonstimulants, how they are chosen, and what to know about safety.
The basics
- How ADHD medications work in adults
How ADHD medications work: what FDA labels say about dopamine and norepinephrine, stimulants vs nonstimulants, and how large the effect is in adults.
- Stimulant vs nonstimulant ADHD medication for adults
Stimulant vs nonstimulant ADHD medication for adults: how they differ on evidence, warnings and controlled status, and when guidelines suggest a nonstimulant.
- How doctors choose an ADHD medication for adults
How doctors choose an ADHD medication for adults: history, heart health, mood, other drugs, daily schedule, misuse risk and cost, per labels and guidelines.
- Extended-release ADHD medications explained: beads, pumps, prodrugs and patches
Extended-release ADHD medications explained in plain words: osmotic tablets, bead capsules, prodrugs, evening-dosed capsules and patches, from FDA labels.
- ADHD medication schedules: Schedule II, Schedule IV and unscheduled drugs
Which ADHD medications are Schedule II, Schedule IV or not controlled, and what that means for refills, supply and telehealth in New York and New Jersey.
Side effects and safety
- ADHD medication side effects in adults
Common and serious side effects of adult ADHD medications from FDA labels, when to call your prescriber, and when to get emergency care.
- ADHD medication drug interactions
ADHD medication interactions from FDA labels: MAOIs, SSRIs and serotonin syndrome, antacids, acid reducers, blood pressure drugs, anesthesia and more.
- ADHD medication misuse and addiction risk: what the evidence shows
Can ADHD medication lead to addiction? The FDA boxed warning, what large studies show about treated ADHD and substance use, and how to lower risk.
Compare
Medications and how they compare
Each medication on its own page, and side-by-side comparisons.
The basics
- Generic ADHD medications and authorized generics: what "equivalent" means
Generic ADHD medications explained: FDA AB ratings, the generic Concerta downgrade, authorized generics, and NY and NJ substitution rules as of October 2026.
Stimulant medications
- Adderall (immediate-release amphetamine salts) for adults
Adderall IR for adult ADHD: what the FDA label covers for adults, forms, boxed warning, side effects, interactions, the shortage, and NY and NJ rules.
- Adderall XR for adults: what the FDA label says
Adderall XR for adult ADHD: FDA adult approval, how the bead capsule works, adult side effects, boxed warning, interactions, and NY and NJ rules.
- Vyvanse (lisdexamfetamine) for adults
Vyvanse for adult ADHD: how the prodrug works, adult and binge eating approvals, adult studies, side effects, generics since 2023, NY and NJ rules.
- Mydayis for adults: long-acting mixed amphetamine salts
Mydayis for adult ADHD: FDA approval for ages 13 and up, a three-bead capsule lasting up to 16 hours, side effects, generic status, NY and NJ rules.
- Dextroamphetamine (Dexedrine, Zenzedi) for adults
Dextroamphetamine for adults: oral labels cover ADHD only to age 16, so adult use is off-label. Tablets, Spansule, liquid, warnings, NY and NJ rules.
- Amphetamine liquids, dissolving tablets and the patch: which are approved for adults?
Xelstrym, Adzenys XR-ODT, Dyanavel XR and Evekeo: which amphetamine liquids, dissolving tablets and patches are FDA-labeled for adults (Oct 2026).
- Ritalin (methylphenidate) for adults: what the FDA label says
Is Ritalin approved for adults? Ritalin tablets and generic ER tablets are; Ritalin LA is labeled for ages 6 to 12 only. Forms, warnings, NY/NJ rules.
- Concerta for adults: label, side effects and generics
Concerta is FDA-approved for ADHD from age 6 to 65. Adult side effects, swallow-whole rules, generic Concerta history and NY/NJ rules, per the label.
- Focalin and Focalin XR (dexmethylphenidate) for adults
Focalin XR was studied in adults 18 to 60; Focalin tablets only in ages 6 to 17. Forms, side effects, warnings and NY/NJ rules, per the FDA label.
- Azstarys (serdexmethylphenidate and dexmethylphenidate) for adults
Azstarys is FDA-approved for ADHD from age 6 with no upper limit. How the prodrug works, adult evidence, warnings, no generic yet, and NY/NJ rules.
- Methylphenidate patch, liquids and other forms: which are approved for adults
Daytrana, Jornay PM, Relexxii, Quillivant, QuilliChew and Cotempla: which methylphenidate forms are FDA-labeled for adults and which are child-only.
Nonstimulant medications
- Strattera (atomoxetine) for adults with ADHD
Atomoxetine (Strattera) for adult ADHD: FDA approval, forms, boxed warning, liver warning, side effects, interactions and NY/NJ rules.
- Qelbree (viloxazine) for adults with ADHD
Qelbree (viloxazine) for adult ADHD: 2022 adult approval, CYP1A2 interactions, boxed warning, side effects, pregnancy and NY/NJ rules.
- Guanfacine and clonidine for ADHD in adults
Guanfacine ER (Intuniv) and clonidine ER for adult ADHD: what FDA labels cover, why adult use is off-label, evidence, warnings and tapering.
- Bupropion (Wellbutrin) for ADHD in adults
Bupropion (Wellbutrin) for adult ADHD is off-label. What FDA labels approve, the low-quality evidence, seizure and boxed warnings, interactions.
- Centanafadine (Simtriyo): approval and availability
Simtriyo (centanafadine) for adult ADHD: FDA approval, why it awaits DEA scheduling, stimulant label, boxed warnings and NY/NJ rules.
- Other off-label ADHD medications for adults
Modafinil, tricyclics like desipramine and antipsychotic add-ons for adult ADHD: FDA status, the evidence, safety and why they are not first-line.
Comparisons
- Adderall vs Vyvanse for adults: how they compare
Adderall vs Vyvanse for adult ADHD: how each delivers amphetamine, FDA adult approval, forms, side effects, generics and October 2026 shortages.
- Adderall vs Ritalin for adults: amphetamine or methylphenidate
Adderall vs Ritalin for adult ADHD: amphetamine vs methylphenidate, FDA adult labeling, forms, side effects, warnings and what research shows.
- Concerta vs Ritalin for adults: same drug, different release
Concerta vs Ritalin for adult ADHD: both are methylphenidate. How release, timing, forms, warnings, generics and October 2026 supply compare.
- Vyvanse vs Concerta for adults: amphetamine or methylphenidate, once a day
Vyvanse vs Concerta for adult ADHD: two once-daily stimulants from different families. Labels, forms, side effects, research and supply compared.
- Strattera vs Qelbree: the two non-stimulants approved for adults
Strattera (atomoxetine) vs Qelbree (viloxazine) for adult ADHD: interactions, warnings, side effects, forms and generic status from FDA labels.
- Stimulants vs Strattera (atomoxetine) for adult ADHD
Stimulants vs Strattera (atomoxetine) for adult ADHD: what network meta-analyses and guidelines show, warnings, misuse risk and NY/NJ rules.
- Adderall IR vs Adderall XR for adults: what actually differs
Adderall IR vs Adderall XR for adults: same amphetamine salts, different release. Adult labeling, timing, food, sprinkling and October 2026 supply.
- Methylphenidate vs amphetamine: what research shows in adults
Methylphenidate vs amphetamine for adult ADHD: what network meta-analyses and head-to-head trials show, guideline advice and label differences.
- Focalin vs Ritalin for adults: dexmethylphenidate or methylphenidate
Focalin vs Ritalin for adult ADHD: dexmethylphenidate vs racemic methylphenidate, adult labeling, IR and XR forms, side effects and generics.
- Brand vs generic Concerta: are the generics the same?
Brand vs generic Concerta: FDA's 2014 downgrade, which generics are AB-rated in October 2026, the BX product, and how to check your manufacturer.
Side effects and safety
- ADHD medication and sleep
How ADHD stimulants and nonstimulants affect sleep in adults: insomnia rates from FDA labels, what sleep studies found, and what to tell a prescriber.
- ADHD medication, appetite and weight
How ADHD medications affect appetite and weight in adults, from FDA label trials, plus what monitoring involves and why they are not for weight loss.
- ADHD medication and anxiety
Can ADHD medication cause or ease anxiety? FDA label rates for adults, research on ADHD with anxiety, and interactions with anxiety medications.
- Drinking alcohol on ADHD medication
What FDA labels and research say about alcohol with ADHD medication: faster release from some capsules, higher drug levels, sedation and liver risks.
- ADHD medication tolerance and wearing off: why it seems to stop working
Is it tolerance or wearing off? What FDA labels and studies say about ADHD medication losing effect, and other causes such as generic switches.
- ADHD medication and caffeine: is it safe to drink coffee?
Can you drink coffee on ADHD medication? What FDA labels say, how caffeine and stimulant side effects overlap, and why Qelbree is different.
- ADHD medication and mood changes: irritability, flatness, mania and psychosis
Irritability, feeling flat, depression, mania or psychosis on ADHD medication: what FDA labels warn, what studies show, and when to get help.
Before you start
Before you start or stop
Questions to ask and how to plan changes with your prescriber.
Side effects and safety
- Stopping ADHD medication: what happens and how to plan it
What FDA labels say about stopping ADHD medication, withdrawal signs, whether symptoms return, and how to plan a trial off it with a prescriber.
- Questions to ask before starting ADHD medication: a checklist for adults
Questions to ask before starting ADHD medication: history to share, side effects, interactions, pregnancy, and NY and NJ prescription rules.
More guides
- The New York Adult ADHD Guide
A complete guide to adult ADHD in New York State: getting evaluated, medication and prescribing rules, cost and insurance, your rights at work and school, and finding care.
- The New Jersey Adult ADHD Guide
Adult ADHD in New Jersey: getting evaluated, NJ prescribing and telehealth rules, insurance and NJ FamilyCare, your rights under the LAD, and finding care by region.
- The Adult ADHD Symptoms Guide
What adult ADHD looks like at work, at home and in relationships, the conditions that look like it, and when an evaluation makes sense.
Questions
Which ADHD medications are FDA-approved for adults?
Among others, Adderall XR, Vyvanse, Ritalin tablets, Concerta (up to age 65), Focalin XR, Azstarys, the Xelstrym patch, Strattera and Qelbree carry adult approval. Some familiar products, such as Intuniv, the Daytrana patch and Dexedrine, are labeled only for children and teens, so adult use is off-label. Each medication page in this guide states what its label says about adults.
Why doesn't this guide list doses?
Doses depend on the medication, the form, your health, other medicines you take and how you respond, and they are adjusted over time by a prescriber. A number on a web page can mislead more than it helps, so the guide describes forms and how long each lasts in words instead.
Is a stimulant or a nonstimulant usually tried first?
NICE recommends lisdexamfetamine or methylphenidate as first-line treatment for adults, and atomoxetine for adults who cannot tolerate them or whose symptoms have not responded to separate 6-week trials of each. A 2024 American Family Physician review says nonstimulants are used when stimulants are contraindicated, not tolerated or ineffective. Your history can change that order, which is why the choice is made with a prescriber.
Are ADHD stimulants addictive?
They can be misused, and every stimulant label carries a boxed warning on abuse, misuse and addiction. Large studies of people with ADHD taking medication as prescribed found lower, not higher, odds of substance-related emergencies during months on medication. Prescribers are told to assess misuse risk before starting and throughout treatment.
Can I get centanafadine (Simtriyo) yet?
Not as of October 19, 2026. The FDA approved it on July 24, 2026, but its approval letter says it may be marketed only after the DEA publishes a scheduling rule, and no such rule had appeared in the Federal Register by that date.
Can ADHD medication be prescribed by telehealth in New York and New Jersey?
As of October 2026, yes, under a federal extension that runs through December 31, 2026. New York's rule follows the federal one. New Jersey adds its own requirement: adults located in New Jersey who start a stimulant by telehealth need an in-person visit within 30 days and at least once a year, with a contact every three months.
Sources
- NICE guideline NG87: Attention deficit hyperactivity disorder, diagnosis and management, recommendations (last updated September 13, 2019)
- American Family Physician: Attention-Deficit/Hyperactivity Disorder in Adults, Olagunju and Ghoddusi (August 2024)
- APSARD: Guidelines page, US adult ADHD guideline status (checked October 19, 2026)
- Cortese et al., Lancet Psychiatry 2018;5(9):727-738: network meta-analysis of ADHD medications in children, adolescents and adults
- Ostinelli et al., Lancet Psychiatry 2025;12(1):32-43: component network meta-analysis of interventions for ADHD in adults (PubMed)
- US Food and Drug Administration: FDA updating warnings to improve safe use of prescription stimulants (May 11, 2023)
- DailyMed: Adderall XR prescribing information and Medication Guide (label effective April 30, 2026)
- DailyMed: Vyvanse (lisdexamfetamine) prescribing information (label effective April 30, 2026)
- DailyMed: Concerta (methylphenidate extended-release) prescribing information (label effective April 20, 2026)
- DailyMed: Ritalin (methylphenidate hydrochloride) tablets prescribing information
- DailyMed: Mydayis prescribing information (label updated April 30, 2026)
- DailyMed: Dexedrine Spansule (dextroamphetamine sulfate) prescribing information
- DailyMed: Xelstrym (dextroamphetamine transdermal system) prescribing information
- DailyMed: Focalin XR (dexmethylphenidate) extended-release capsules prescribing information
- DailyMed: Azstarys (serdexmethylphenidate and dexmethylphenidate) prescribing information
- DailyMed: Strattera (atomoxetine) prescribing information (label dated June 30, 2026)
- DailyMed: Qelbree (viloxazine) prescribing information (label dated December 5, 2025)
- DailyMed: Intuniv (guanfacine extended-release) prescribing information
- DailyMed: Daytrana (methylphenidate transdermal system) prescribing information
- FDA: NDA 218145 approval letter for Simtriyo (centanafadine), including controlled substance scheduling terms
- Federal Register: documents mentioning centanafadine (no DEA scheduling notice as of October 19, 2026)
- Quinn et al., American Journal of Psychiatry 2017;174(9):877-885: ADHD medication and substance-related problems
- Han et al., JAMA Psychiatry 2025;82(6):572-581: prescription stimulant use, misuse and use disorder among US adults
- openFDA drug shortages: mixed amphetamine salts tablets, status Current (checked October 19, 2026)
- openFDA drug shortages: lisdexamfetamine, status Current (checked October 19, 2026)
- eCFR: 21 CFR 1308.12, Schedule II
- eCFR: 21 CFR 1306.12, Refilling prescriptions; issuance of multiple prescriptions
- New York Codes, Rules and Regulations: 10 NYCRR 80.67, Schedule II and certain other substances
- New Jersey Administrative Code 13:35-7.6: Limitations on prescribing controlled dangerous substances (Cornell LII)
- New Jersey Legislature: P.L.2026, c.40 (telehealth prescribing of Schedule II stimulants, effective July 8, 2026)
- Federal Register: Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (December 31, 2025)
- US Food and Drug Administration: Orange Book data files (data dated October 9, 2026)